NCT00938288 - A Study of KW-3357 in Congenital Antithrombin Deficiency | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

April 30, 2009

Primary Completion Date

December 22, 2010

Study Completion Date

April 30, 2011

Conditions

Congenital Antithrombin Deficiency

Interventions

DRUG

KW-3357

50IU/mL, IV single dose

Trial Locations (8)

30625

Department of Haemotogy, Haemastasy, Oncology and Stem Cell Transplantation, Hannover Medical School, Hanover

SE-205 02

Center for Thrombosis and Haemostasis, Malmo University Hospital, Malmo

SE-171 76

Dept Obst Gyn/Section for Women and Child Health/Clinical Trial Unit, Karolinska University Hospital, Stockholm

TR1 3LJ

Treliske, Haematology Clinic, Royal Cornwall Hospital, Truro

BS2 8ED

Bristol Haemophia Care Centre, Bristol Haemotology and Oncology Centre, Bristol

G4 0SF

Department of Haemotology, Glasgow Royal Infirmary, Glasgow

SE1 7EH

Kings College, Dept of Haematology, Lupus & Pathology Guy's and St Thomas Trust, St Thomas Hospital, Ctr for Haemostasis and Thrombosis (the Haemophia Reference Ctr), London

WIT 4EU

University College London Hospital NHS Trust, London